Clinical Trial Update: Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a new antidepressant for major depressive disorder has completed enrollment/status; sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED